Vascular Anomalies in Patients with Growth Hormone-secreting Pituitary Adenomas: Illustrative Case Report and Systematic Review of the Literature
Overview
Authors
Affiliations
Purpose: Endonasal resection is the first-line treatment for patients harboring growth hormone (GH)-secreting pituitary adenomas. The complexity of the parasellar neurovascular structures makes pre-operative diagnostic imaging essential to understanding the anatomy of this region. We aimed to describe vascular anomalies in acromegalic patients and emphasize their relevance for surgery and preoperative planning.
Methods: A systematic review following the PRISMA statement was performed in July 2021.
Results: Thirty-three studies were evaluated. Elevated GH and insulin-like growth factor-1 (IGF-1) levels are linked to the occurrence of cardiovascular risk factors. This is attributed to endothelial dysfunction, mainly caused by changes in flow-mediated dilatation (FMD), which is probably the main cause of vascular anomalies in acromegaly. The occurrence of protrusions of the internal carotid artery (ICA) (35-53%), a narrow intercarotid distance, and an asymmetrical course was described. In 13-18% of acromegalic patients, the presence of an intracerebral aneurysm could be reported (incidence in the general population:0.8-1.3%). The selected studies were however performed with a small patient sample (range:1-257). We present a case report of a 57y/o male patient with anomalies of the ICA ("kissing carotid arteries") harboring a GH-secreting adenoma, which was resected via an endoscopic endonasal approach.
Conclusions: There is an association between acromegaly and endothelial dysfunction, which increases cardiovascular risk factors and vascular anomalies. Preoperative vascular imaging, e.g., CT angiography, should be implemented as a standard to identify patients at risk and estimate surgical morbidity. However, no evidence-based recommendations exist so far, so future studies are necessary.
Glymphatic transport is reduced in rats with spontaneous pituitary tumor.
Li L, Ding G, Zhang L, Luo H, Davoodi-Bojd E, Li Q Front Med (Lausanne). 2023; 10:1189614.
PMID: 37601793 PMC: 10436560. DOI: 10.3389/fmed.2023.1189614.
Alnaaim S, Al-Kuraishy H, Zailaie M, Alexiou A, Papadakis M, Saad H Acta Neurol Belg. 2023; 124(3):755-766.
PMID: 37584889 PMC: 11139727. DOI: 10.1007/s13760-023-02354-3.
Sivakumar W, Couldwell W Pituitary. 2023; 26(2):259-260.
PMID: 36932285 DOI: 10.1007/s11102-023-01306-7.